 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
「セキュアペイメントロゴ」はインターネットを通じた安全な決済システムを示すロゴです。 |
 |
 |
 |
 |
 |
 |
 |
 |
|
 |
 |
実在性の証明とプライバシー保護のために日本ベリサインのサーバーIDを導入し、SSL暗号化通信を実現しています。 |
 |
 |
 |
 |
 |
 |
 |
|
 |
 |
 |
Adobe eBook(洋書)
|
 |
God’s Favorite House‐If You Build It, He Will Come
Tommy Tenney 著
|
 |
 |
 |
| This volume considers the application of clinical assessment to the drug development process. Important topics include the genetics of and sleep-related breathing disturbances in COPD. |
 |
|
 |
|
 |
 |
 |
 |
 |
 |

Introduction: Claude Lenfant, M.D.
Preface
Contributors
THE APPLICATION OF CLINICAL ASSESSMENT TO THE DRUG DEVELOPMENT PROCESS
Providing Evidence of Therapeutic Benefit in Clinical Drug Development
Steven Kesten and Theodore J. Witek
MEASURING OUTCOMES
Physiology
Use of Expiratory Airflows and Lung Volumes to Assess Outcomes in COPD
Gary T. Ferguson
Exercise Testing
Denis E. O’Donnell and Katherine A. Webb
Sleep-Related Breathing Disturbances in COPD
Walter T. McNicholas
Airway and Alveolar Determinants of Airflow Limitation in COPD
Noe Zamel
Gas Exchange
Antoni Ferrer, Joan Albert BarberÀ, and Roberto Rodriguez-Roisin
Laboratory
Genetics of COPD
Jian-Qing He, Ikuma Kasuga, and Peter D. Pare
Health Outcomes
Dyspnea
Donald A. Mahler
Exacerbations of COPD
Jadwiga A. Wedzicha
Health Status Measurement in COPD
Paul W. Jones
Health Resource Utilization
Mitchell Friedman
SPECIFIC THERAPY
Anticholinergics
Peter J. Barnes
ß-Adrenergic Receptor Agonist Bronchodilators in the Treatment of COPD
Steven I. Rennard
Theophylline and Phosphodiesterase Inhibitors in COPD
Alicia R. ZuWallack and Richard L. ZuWallack
Corticosteroids in COPD
Mario Cazzola, Maria Gabriella Matera, and Roman Pauwels
Antioxidants and Protease Inhibitors
Mario Cazzola and Maria Gabriella Matera
An Integrated Approach to the Pharmacological Therapy of COPD
Bartolome R. Celli
Index |
 |
 |
 |
 |
 |
 |
 |
|
|